VIA
SWAV

Vident Investment Advisory’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Vident Investment Advisory’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,087
Closed -$881K – 1145
2023
Q2 		$881K Buy
+3,087
New +$857K 0.03% 513

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Vident Investment Advisory's SWAV Position: Q3 2023 in Review

Vident Investment Advisory sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 3,087 shares — an estimated $881K sold.

Vident Investment Advisory first reported a position in SWAV in Q2 2023 and held it in 1 quarter. The position peaked at $881K in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Vident Investment Advisory reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 3,087 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $881K.
  • Vident Investment Advisory first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Vident Investment Advisory's Shockwave Medical, Inc. Common Stock position peaked at $881K in Q2 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.